Početna › Difuzni veliki B-stanični limfom › Nebraska › Omaha
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Omaha, NE
9 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Omaha i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
U tijeku regrutacijaFaza 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi udaljenosti
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
U tijeku regrutacijaFaza 2/3
- Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- University Of Nebraska Medical Center ( Site 0110), Omaha
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
U tijeku regrutacijaFaza 1
- The University of Nebraska Medical Center, Omaha
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
U tijeku regrutacijaFaza 2
- Nebraska Cancer Specialists, Omaha
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- University of Nebraska Medical Center, Omaha
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- University of Nebraska Medical Center (UNMC), Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
U tijeku regrutacijaFaza 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
U tijeku regrutacijaFaza 2
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Nashville, TN15 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Durham, NC14 studija
- Dallas, TX13 studija
Ostale studije u gradu Omaha
- Rak prostate27 studija
- Nemikrocelularni karcinom pluća24 studija
- Rak dojke22 studija
- Kolorektalni rak18 studija
- Rak (sve vrste)18 studija
- Multipli mijelom16 studija
- Non-Hodgkinov limfom14 studija
- Rak jajnika14 studija
- Rak gušterače14 studija
- Pločastostanični karcinom glave i vrata13 studija
- Srčano zatajenje13 studija
- Metastatski karcinom13 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.